67 related articles for article (PubMed ID: 16078603)
1. [Atherosclerotic lesion of the vessels in systemic lupus erythematosus in males: relations with concentration of C-reactive protein].
Il'ina AE; Kliukvina NG; Aleksandrova EN; Popkova TV; Novikov AA; Mach ES; Bulgakova OV; Nasonova EL
Ter Arkh; 2005; 77(6):61-5. PubMed ID: 16078603
[TBL] [Abstract][Full Text] [Related]
2. [Atheroscleotic vascular lesion in systemic lupus erythematosus and antiphospholipid syndrome in men].
Il'ina AE; Kliukvina NG; Aleksandrova EN; Popkova TV; Novikov AA; Mach ES; Bulgakova OV; Nasonov EL
Klin Med (Mosk); 2006; 84(4):23-8. PubMed ID: 16755850
[TBL] [Abstract][Full Text] [Related]
3. [Soluble CD40 ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection].
Popkova TV; Panafidina TA; Aleksandrova EN; Novikova DS; Novikov AA; Alekberova ZS; Mach ES; Nasonov EL
Ter Arkh; 2008; 80(5):37-41. PubMed ID: 18590112
[TBL] [Abstract][Full Text] [Related]
4. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.
Jiménez S; García-Criado MA; Tàssies D; Reverter JC; Cervera R; Gilabert MR; Zambón D; Ros E; Bru C; Font J
Rheumatology (Oxford); 2005 Jun; 44(6):756-61. PubMed ID: 15757967
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular diseases in rheumatoid arthritis].
Popkova TV; Khelkovskaia AN; Mach ES; Aleksandrova EN; Novikov AA; Novikova DS; Nasonov EL
Ter Arkh; 2007; 79(5):9-14. PubMed ID: 17672067
[TBL] [Abstract][Full Text] [Related]
6. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus.
Falaschi F; Ravelli A; Martignoni A; Migliavacca D; Sartori M; Pistorio A; Perani G; Martini A
Arthritis Rheum; 2000 Jun; 43(6):1405-9. PubMed ID: 10857801
[TBL] [Abstract][Full Text] [Related]
7. [Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis].
Panafidina TA; Popkova TV; Alekberova ZS; Mach ES; Aleksandrova EN; Nasonov EL
Ter Arkh; 2008; 80(5):41-6. PubMed ID: 18590113
[TBL] [Abstract][Full Text] [Related]
8. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.
Shimada Y; Asanuma YF; Yokota K; Yoshida Y; Kajiyama H; Sato K; Akiyama Y; Mimura T
Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
Roman MJ; Shanker BA; Davis A; Lockshin MD; Sammaritano L; Simantov R; Crow MK; Schwartz JE; Paget SA; Devereux RB; Salmon JE
N Engl J Med; 2003 Dec; 349(25):2399-406. PubMed ID: 14681505
[TBL] [Abstract][Full Text] [Related]
12. [The significance of cardiovascular risk factors and C-reactive protein to the development of atherosclerosis in women with systemic lupus erythematosus].
Panafidina TA; Popkova TV; Alekberova ZS; Novikova PS; Mach ES; Aleksandrova EN; Kashnikova LN; Nasonov EL
Klin Med (Mosk); 2006; 84(10):49-54. PubMed ID: 17201275
[TBL] [Abstract][Full Text] [Related]
13. Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study.
Wolak T; Todosoui E; Szendro G; Bolotin A; Jonathan BS; Flusser D; Buskila D; Sukenik S; Abu-Shakra M
J Rheumatol; 2004 May; 31(5):909-14. PubMed ID: 15124249
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
[TBL] [Abstract][Full Text] [Related]
15. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
Maksimowicz-McKinnon K; Magder LS; Petri M
J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
[TBL] [Abstract][Full Text] [Related]
16. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
17. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
18. [Antiendothelial cell antibodies as a risk factor of atherosclerosis in systemic lupus erythematosus].
Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
Ann Acad Med Stetin; 2006; 52 Suppl 2():95-9. PubMed ID: 17471843
[TBL] [Abstract][Full Text] [Related]
19. [The condition of peripheral arteries in patients with systemic lupus erythematosus].
Alekberova ZS; Mach ES; Gerasimova EV; Popkova TV; Nasonov EL
Klin Med (Mosk); 2004; 82(4):46-9. PubMed ID: 15164509
[TBL] [Abstract][Full Text] [Related]
20. Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patient.
Smrzova A; Horak P; Skacelova M; Hermanova Z; Langova K; Zadrazil J; Novotny D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):404-11. PubMed ID: 23945845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
